数字政府解决方案
Search documents
受毛利率下降影响,南威软件2025年预亏3.8亿元-4.56亿元
Ju Chao Zi Xun· 2026-01-21 03:25
Core Viewpoint - The company, Nanwei Software, anticipates a significant net loss for the fiscal year 2025, with projected losses ranging from 456 million to 380 million yuan, primarily due to increased impairment provisions and ongoing investments in new business areas [2][3]. Group 1: Financial Performance - The expected net profit attributable to the parent company for 2025 is projected to be between -456 million and -380 million yuan, with a net profit excluding non-recurring losses estimated between -472 million and -396 million yuan [2]. - The company plans to recognize approximately 220 million yuan in impairment provisions, which is an increase of about 143 million yuan compared to the previous year [3]. - After excluding the impact of impairment, the adjusted net profit is expected to range from -246 million to -170 million yuan, and the adjusted net profit excluding non-recurring losses is projected to be between -262 million and -186 million yuan [2]. Group 2: Business Development and Strategy - Despite a contraction in domestic market demand and intensified competition, the company's G-end main business achieved a year-on-year revenue increase, although net profit was negatively impacted by declining gross margins [3]. - The company is actively pursuing AI transformation and business restructuring, aiming to establish a comprehensive AI capability and create barriers in the digital government sector [4]. - The launch of high-performance computing servers at the Beijing Qixingyuan Digital Economy Industry Center marks the commercialization of its computing business, laying the foundation for new growth [4]. Group 3: Market Expansion and Future Prospects - The company has made breakthroughs in overseas markets, with successful project completions in Algeria and opportunities emerging in Singapore, Saudi Arabia, South Africa, and Pakistan, potentially leading to orders in 2026 [4]. - The health initiative, Chashou Health, has transitioned from a strategic blueprint to a commercial value realization, which is expected to become a new growth driver [4]. - The company reported a stock order value of 2.412 billion yuan for 2025, reflecting a year-on-year increase of 10.54%, providing a solid foundation for stable operations [4].